Warning from competitors

A marketing authorization holder for non-prescription drugs was in a conflict with a competitor. We drafted warning letters for the marketing authorization holder and were thus able to bring them to a round table.

A discussion was held between both parties, which was concluded with an amicable solution.

We support companies in dispute resolution in all areas of life science law (e.g. contract performance, distribution, promotion).